Filter
409
Text search:
Clinical
characterization
Featured
Recommendations
46
New Publications
71
Language
Document type
No document type
145
Guidelines
101
Studies & Reports
88
Manuals
30
Strategic & Response Plan
22
Fact sheets
17
Situation Updates
4
Training Material
2
Countries / Regions
Latin America and the Carribbean
17
Global
17
India
16
Africa
14
Brazil
11
Kenya
8
Nigeria
6
Uganda
5
South Africa
5
Colombia
5
West and Central Africa
5
Venezuela
5
Germany
4
East and Southern Africa
4
Western Pacific Region
4
Liberia
3
Ghana
3
Philippines
3
Tanzania
3
Mozambique
3
Namibia
3
Angola
3
Middle East and North Africa
3
Russia
3
Burkina Faso
2
Sierra Leone
2
Congo, Democratic Republic of
2
USA
2
Cameroon
2
Zimbabwe
2
Zambia
2
Peru
2
Bolivia
2
Chile
2
Western and Central Europe
2
Tajikistan
2
Guinea-Bissau
1
Ethiopia
1
Haiti
1
Nepal
1
Pakistan
1
Jordan
1
Afghanistan
1
Syria
1
Cambodia
1
Rwanda
1
Indonesia
1
Bangladesh
1
Malawi
1
Benin
1
Argentina
1
Eswatini/ Swaziland
1
Ukraine
1
Ecuador
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Eastern Europe
1
Vietnam
1
France
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
102
Clinical Guidelines
52
Public Health
22
Pharmacy & Technologies
20
Key Resources
10
Women & Child Health
5
Capacity Building
3
Toolboxes
COVID-19
73
Rapid Response
53
AMR
40
NTDs
29
HIV
16
Pharmacy
16
TB
15
Mental Health
12
Ebola
10
Zika
10
Planetary Health
9
NCDs
6
Cholera
5
Disability
4
Natural Hazards
3
Caregiver
3
Polio
2
Conflict
2
Refugee
2
Specific Hazards
2
Global Health Education
1
Health Financing Toolbox
1
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t
...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv
...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This
...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis
...
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience
...
Event-based surveillance (EBS) is defined as the organized collection, monitoring, assessment and interpretation of mainly unstructured ad hoc information regarding health events or risks, which may represent an acute risk to health. Both indicator-based and event-based surveillance components serve
...
Due to the particular Amazonian situation of vectorial transmission based mostly on the wild cycle of Trypanosoma cruzi with diversity of triatomine vectors involved in effective transmission, and the variety of eco-epidemiological situations that facilitate such transmission, the countries of the A
...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re
...
interim guidance, 25 November 2024
The aim of this document is to provide interim guidance for interventions to reduce the risk of maternal Zika virus infection and to manage potential complications during pregnancy. This guidance is based on the best available research evidence and covers areas prioritized by an international, multi
...
1 February 2021 to 31 January 2022
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious Dis
...
29 September 2021
